UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary Group

European urology, 2003-11, Vol.44 (5), p.519

2003

Volltextzugriff (PDF)

Assessing the quality of economic evaluations of health care interventions

Annals of oncology, 2000-12, Vol.11 (12), p.1513-1515

Neymark, N

2000

Volltextzugriff (PDF)

The costs of treating glaucoma with combinations of topical drugs in Spain

European journal of ophthalmology, 2008-01, Vol.18 (1), p.52-59

2008

Volltextzugriff (PDF)

Critical reviews of economic analyses in order to make health care decisions for cancer

Annals of oncology, 1998-11, Vol.9 (11), p.1167-1172

NEYMARK, N

1998

Volltextzugriff (PDF)

Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel Plus Gemcitabine in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group—EORTC 08975

Journal of clinical oncology, 2003-11, Vol.21 (21), p.3909-3917

2003

Volltextzugriff (PDF)

First European conference on the economics of cancer

European journal of cancer (1990), 1998-05, Vol.34 (6), p.809-809

Neymark, N

1998

Volltextzugriff (PDF)

The costs of managing patients with advanced colorectal cancer in 10 different European centres

European journal of cancer (1990), 1999-12, Vol.35 (13), p.1789-1795

1999

Volltextzugriff (PDF)

Moving beyond acquisition cost reductionism

Supportive care in cancer, 1998-11, Vol.6 (6), p.488-489

Neymark, N

1998

Volltextzugriff (PDF)

Health Economics Unit achievements

European journal of cancer (1990), 2002-03, Vol.38, p.147-150

2002

Volltextzugriff (PDF)

Estimating survival gain for economic evaluations with survival time as principal endpoint: A cost-effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer

Health economics, 2002-04, Vol.11 (3), p.233-248

2002

Volltextzugriff (PDF)

Assessing the economic value of anticancer therapies

Recent results in cancer research, 1998, Vol.148, p.1

Neymark, N

1998

Volltextzugriff (PDF)

Patient management strategies and transplantation techniques in european stem cell transplantation centers offering breast cancer patients high-dose chemotherapy with peripheral blood stem cell support: a joint report from the EORTC and EBMT

Haematologica (Roma), 2000-07, Vol.85 (7), p.733

2000

Volltextzugriff (PDF)

Cost-effectiveness of the addition of early hormonal therapy in locally advanced prostate cancer: results decisively determined by the cut-off time-point chosen for the analysis

European journal of cancer (1990), 2001-09, Vol.37 (14), p.1768-1774

2001

Volltextzugriff (PDF)

Cost effectiveness of paclitaxel/cisplatin compared with cyclophosphamide/cisplatin in the treatment of advanced ovarian cancer in Belgium

PharmacoEconomics, 2002, Vol.20 (7), p.485-497

2002

Volltextzugriff (PDF)

Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: report of a workshop

European journal of cancer (1990), 1998-08, Vol.34 (9), p.1317-1333

1998

Volltextzugriff (PDF)

Impact of emesis on clinical and economic outcomes of cancer therapy with highly emetogenic chemotherapy regimens: a retrospective analysis of three clinical trials

Supportive care in cancer, 2005-10, Vol.13 (10), p.812-818

2005

Volltextzugriff (PDF)

Strontium89 Chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer : A phase iii study of the European Organisation for Research and Treatment of Cancer Genitourinary Group

European urology, 2003-11, Vol.44 (5), p.519-526

2003

Volltextzugriff (PDF)

Economics of Urinary Tract Cancers: State of the Art

European urology, 1997-01, Vol.31 (Suppl 1), p.72-81

1997

Volltextzugriff (PDF)

Impact of the Treating Institution on Survival of Patients With“Poor-Prognosis” Metastatic Nonseminoma

JNCI : Journal of the National Cancer Institute, 1999-05, Vol.91 (10), p.839-846

1999

Volltextzugriff (PDF)

Determining and comparing the costs of treatments

European journal of cancer (1990), 1999-09, Vol.35, p.S312-S312

Neymark, N.

1999

Volltextzugriff (PDF)

Techniques for health economics analysis in oncology: part 2

Critical reviews in oncology/hematology, 1999-03, Vol.30 (1), p.13-24

Neymark, Niels

1999

Volltextzugriff (PDF)

Techniques for health economics analysis in oncology: part 1

Critical reviews in oncology/hematology, 1999-03, Vol.30 (1), p.1-11

Neymark, Niels

1999

Volltextzugriff (PDF)

Economics of Cancer

European journal of cancer (1990), 2001, Vol.37 (14)

2001

Volltextzugriff (PDF)

Health Economics

Critical reviews in oncology/hematology, 1999-11, Vol.32 (2)

NEYMARK, Niels

1999

Volltextzugriff (PDF)

Assessment of the economic value of epoetin use in anemic cancer patients

Expert review of pharmacoeconomics & outcomes research, 2001-12, Vol.1 (2), p.167-175

Neymark, Niels

2001

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(65)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Humans
(32)
Life Sciences & Biomedicine
(28)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Male
(15)
Oncology
(14)
Neoplasms - Economics
(10)
Middle Aged
(9)
Tumors
(9)
Adult
(8)
Cost-Benefit Analysis
(8)
General Aspects
(8)
Europe
(7)
Female
(7)
Neoplasms - Therapy
(6)
Treatment Outcome
(6)
Aged
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Cost Analysis
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary Group

Assessing the quality of economic evaluations of health care interventions

The costs of treating glaucoma with combinations of topical drugs in Spain

Critical reviews of economic analyses in order to make health care decisions for cancer

Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel Plus Gemcitabine in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group—EORTC 08975

First European conference on the economics of cancer

The costs of managing patients with advanced colorectal cancer in 10 different European centres

Moving beyond acquisition cost reductionism

Health Economics Unit achievements

Estimating survival gain for economic evaluations with survival time as principal endpoint: A cost-effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer

Assessing the economic value of anticancer therapies

Patient management strategies and transplantation techniques in european stem cell transplantation centers offering breast cancer patients high-dose chemotherapy with peripheral blood stem cell support: a joint report from the EORTC and EBMT

Cost-effectiveness of the addition of early hormonal therapy in locally advanced prostate cancer: results decisively determined by the cut-off time-point chosen for the analysis

Cost effectiveness of paclitaxel/cisplatin compared with cyclophosphamide/cisplatin in the treatment of advanced ovarian cancer in Belgium

Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: report of a workshop

Impact of emesis on clinical and economic outcomes of cancer therapy with highly emetogenic chemotherapy regimens: a retrospective analysis of three clinical trials

Strontium89 Chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer : A phase iii study of the European Organisation for Research and Treatment of Cancer Genitourinary Group

Economics of Urinary Tract Cancers: State of the Art

Impact of the Treating Institution on Survival of Patients With“Poor-Prognosis” Metastatic Nonseminoma

Determining and comparing the costs of treatments

Techniques for health economics analysis in oncology: part 2

Techniques for health economics analysis in oncology: part 1

Economics of Cancer

Health Economics

Assessment of the economic value of epoetin use in anemic cancer patients

Suchergebnisse filtern